Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Partouche

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Physics in Medicine and Biology|June 2, 2023
An AI-based universal phantom analysis method based on XML-SVG wireframes with novel functional object identifiersAhmad Sakaamini, Alexander Van Slyke, Julien Partouche, et al.
Practical Radiation Oncology|October 4, 2021
Evaluation of Dose Distribution to Organs-at-Risk in a Prospective Phase 1 Trial of Pembrolizumab and Multisite Stereotactic Body Radiation Therapy (SBRT)Annie Xiao, Jason J Luke, Julien Partouche, et al.
Practical Radiation Oncology|March 29, 2014
Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic diseaseKimberly S Corbin, Mark C Ranck, Michael D Hasselle, et al.
International Journal of Radiation Oncology, Biology, Physics|June 26, 2022
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and ImmunotherapyMark C Korpics, Rohan R Katipally, Julien Partouche, et al.
Blood Advances|July 19, 2022
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCTMisha C Tran, Yasmin Hasan, Amy Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2021
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC StudyChristine M Bestvina, Kelli B Pointer, Theodore Karrison, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Physics in Medicine and Biology|June 2, 2023
An AI-based universal phantom analysis method based on XML-SVG wireframes with novel functional object identifiersAhmad Sakaamini, Alexander Van Slyke, Julien Partouche, et al.
Practical Radiation Oncology|October 4, 2021
Evaluation of Dose Distribution to Organs-at-Risk in a Prospective Phase 1 Trial of Pembrolizumab and Multisite Stereotactic Body Radiation Therapy (SBRT)Annie Xiao, Jason J Luke, Julien Partouche, et al.
Practical Radiation Oncology|March 29, 2014
Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic diseaseKimberly S Corbin, Mark C Ranck, Michael D Hasselle, et al.
International Journal of Radiation Oncology, Biology, Physics|June 26, 2022
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and ImmunotherapyMark C Korpics, Rohan R Katipally, Julien Partouche, et al.
Blood Advances|July 19, 2022
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCTMisha C Tran, Yasmin Hasan, Amy Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2021
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC StudyChristine M Bestvina, Kelli B Pointer, Theodore Karrison, et al.
Pageof 1